1.Date of occurrence of the event:2022/06/27
2.Company name:OBI Pharma Inc.
3.Relationship to the Company (please enter ”head office” or ”subsidiaries”):Head office
4.Reciprocal shareholding ratios:Not applicable.
5.Cause of occurrence:Announcement of the status of implementation of the commitments during the up-listing at Taipei Exchange.
6.Countermeasures:The Company committed to disclose amendment of “Procedures for Asset Acquisition & Disposal” on MOPS and submit notice to the Taipei Exchange.
Status:Amendment of “Procedures for Asset Acquisition & Disposal” was resolved at the Annual General Meeting on 2022/06/27. Relevant information was disclosed in the Meeting Handbook page 52 to 60 as published on MOPS.
7.Any other matters that need to be specified:Official notice will be submitted to the Taipei Exchange.